Peritoneal dialysis in patients with refractory congestive heart failure
Keywords:Peritoneal dialysis, cardiac failure
Chronic heart failure is a growing problem. Despite progress in its management, many patients become refractory to therapies including diuretic resistance, major congestion, and worsening renal function. The only alternative to get rid of excess water and sodium is ultrafiltration, which can be achieved via hemodialysis or peritoneal dialysis (PD). The majority of studies have shown multiple benefits of PD as an improvement in functional class, a reduction in hospitalization leading to increased quality of life, and even a reduction in mortality. Being a home dialysis technique, it is more favorably accepted by patients. It remains necessary to confirm these potential positive outcomes and to identify patients who would benefit the most from this treatment in the era of new therapies available to date.
- Mullens W, Damman K, Harjola V, Mebazaa A, Brunner-La Rocca H, Martens P, et al. The use of diuretics in heart failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2019; 21: 137–155.
- Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2016; 37: 2129–2200.
- Núñez J, González M, Miñana G, Garcia-Ramón R, Sanchis J, Bodí V, et al. Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure. European Journal of Heart Failure. 2012; 14: 540–548.
- Ross EA. Congestive renal failure: the pathophysiology and treatment of renal venous hypertension. Journal of Cardiac Failure. 2012; 18: 930–938.
- Hanberg JS, Sury K, Wilson FP, Brisco MA, Ahmad T, Ter Maaten JM, et al. Reduced Cardiac Index is not the Dominant Driver of Renal Dysfunction in Heart Failure. Journal of the American College of Cardiology. 2016; 67: 2199–2208.
- Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation. 2010; 122: 265–272.
- Kazory A, Bargman JM. Defining the role of peritoneal dialysis in management of congestive heart failure. Expert Review of Cardiovascular Therapy. 2019; 17: 533–543.
- Gupta R, Testani J, Collins S. Diuretic Resistance in Heart Failure. Current Heart Failure Reports. 2019; 16: 57–66.
- Bart BA, Goldsmith SR, Lee KL, Givertz MM, O’Connor CM, Bull DA, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. New England Journal of Medicine. 2012; 367: 2296–2304.
- Cnossen TT, Kooman JP, Krepel HP, Konings CJAM, Uszko- Lencer NHMK, Leunissen KML, et al. Prospective study on clinical effects of renal replacement therapy in treatment-resistant congestive heart failure. Nephrology, Dialysis, Transplantation. 2012; 27: 2794–2799.
- Kunin M,Carmon V, Arad M, Levin-Iana M, Freimak D, Holtzman EJ et al. Inflammatory biomarkers in refractory congestive heart failure patients treated with peritoneal dialysis. BioMed Research International. 2015 ; 2015 :590851
- Courivaud C, Kazory A, Crépin T, Azar R, Bresson-Vautrin C, Chalopin J, et al. Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Peritoneal Dialysis International. 2014; 34: 100–108.
- Grossekettler L, Schmack B, Meyer K, Brockmann C, Wanninger R, Kreusser MM, et al. Peritoneal dialysis as therapeutic option in heart failure patients. ESC Heart Failure. 2019; 6: 271–279.
- Sanchez JE, Ortega T, Rodriguez C, Diaz-Molina B, Martin M, Garcia-Cueto C, et al. Efficacy of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. Nephrology Dialysis Transplantation. 2010; 25: 605–610.
- Papasotiriou M, Liakopoulos V, Kehagias I, Vareta G, Ntrinias T, Papachristou E, Goumenos DS. Favorable effects of peritoneal dialysis in patients with refractory heart failure and overhydration. Perit Dial Int. 2022 Jan;42(1):48-56. doi: 10.1177/0896860820970097. Epub 2020 Nov 28. PMID: 33250003
- Kazory A, Bargman JM. Defining the role of peritoneal dialysis in management of congestive heart failure. Expert review of cardiovascular therapy. 2019 ; 17 :533-543.
- Grossekettler L, Schmack B, Brockmann C, Wanninger R, Kreusser MM, Frankenstein L, et al. Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients. BMC Nephrology. 2020; 21: 179.
- Pavo N, Yarragudi R, Puttinger H, Arfsten H, Strunk G, Bojic A, et al. Parameters associated with therapeutic response using peritoneal dialysis for therapy refractory heart failure and congestive right ventricular dysfunction. PLoS ONE. 2018; 13: e0206830.
- Dukka H, Kalra PA, Wilkie M, Bhandari S, Davies SJ, Barratt J, et al. Peritoneal Ultrafiltration for Heart Failure: Lessons from a Randomized Controlled Trial. Peritoneal Dialysis International. 2019; 39 :486-489
- Selby NM, McIntyre CW. Peritoneal Dialysis is not Associated with Myocardial Stunning. Peritoneal Dialysis International. 2011; 31: 27–33.
- Sens F, Schott-Pethelaz A, Labeeuw M, Colin C, Villar E. Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure. Kidney International. 2011; 80: 970–977.
- Van Biesen W, Williams JD, Covic AC, Fan S, Claes K, Lichodziejewska-Niemierko M, et al. Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort. PLoS ONE. 2011; 6: e17148.
How to Cite
Copyright (c) 2022 Raymond AZAR
This work is licensed under a Creative Commons Attribution 4.0 International License.